Actinium Pharmaceuticals (ATNM) Stock Chart & Stock Price History $1.54 +0.05 (+3.02%) As of 09:37 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Actinium Pharmaceuticals Stock Price Performance The Actinium Pharmaceuticals (ATNM) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 21.83%. In the past month, the stock has increased 0.33%, reflecting recent market activity. As of the latest close, Actinium Pharmaceuticals traded at $1.52 with a market cap of $47.26 million and volume of 200,242 shares. Five years ago, the stock traded at a split-adjusted price of $0.35, representing a 338.82% increase over that period. At the time, it had a market cap of $138.23 million and a volume of 5.45 million shares. Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.99%1 Month Performance+0.33%3 Month Performance+22.80%Year-To-Date Performance+21.83%5 Year Performance+338.82% ATNM Stock Chart for Wednesday, July, 16, 2025 ATNM Chart by TradingView Actinium Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$1.57$1.52-3.50%$1.59$1.49200,242 shs$47.26 million07/14/2025$1.52$1.57+3.29%$1.57$1.48121,409 shs$48.98 million07/11/2025$1.55$1.52-1.94%$1.57$1.49203,660 shs$47.42 million07/10/2025$1.58$1.55-1.90%$1.63$1.54263,260 shs$48.35 million07/09/2025$1.43$1.58+10.49%$1.58$1.45267,205 shs$49.29 million07/08/2025$1.42$1.43+0.70%$1.49$1.40202,954 shs$44.61 million07/07/2025$1.44$1.42-1.39%$1.45$1.40184,325 shs$44.30 million07/04/2025$1.44$1.44$1.46$1.42118,732 shs$44.92 million07/03/2025$1.43$1.44+0.70%$1.46$1.42118,732 shs$44.92 million07/02/2025$1.35$1.43+5.93%$1.49$1.35409,667 shs$44.61 million Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$1.40$1.35-3.57%$1.45$1.35471,144 shs$42.12 million06/30/2025$1.42$1.40-1.41%$1.47$1.39366,950 shs$43.67 million06/27/2025$1.62$1.42-12.35%$1.63$1.424.27 million shs$44.30 million06/26/2025$1.65$1.62-1.82%$1.64$1.48404,015 shs$50.54 million06/25/2025$1.70$1.65-2.94%$1.71$1.62164,342 shs$51.47 million06/24/2025$1.52$1.70+11.84%$1.71$1.54369,408 shs$53.03 million06/23/2025$1.50$1.52+1.33%$1.58$1.47483,195 shs$47.42 million06/20/2025$1.46$1.50+2.74%$1.57$1.43255,065 shs$46.79 million06/19/2025$1.46$1.46$1.48$1.41171,602 shs$45.55 million06/18/2025$1.43$1.46+2.10%$1.48$1.41171,602 shs$45.55 million06/17/2025$1.53$1.43-6.54%$1.52$1.43241,731 shs$44.61 million06/16/2025$1.49$1.53+2.68%$1.55$1.48224,620 shs$47.73 million Related Companies Voyager Therapeutics Stock Price Chart Tiziana Life Sciences Stock Price Chart I-Mab Stock Price Chart Lifevantage Stock Price Chart Enanta Pharmaceuticals Stock Price Chart Innate Pharma Stock Price Chart Alpha Cognition Stock Price Chart Journey Medical Stock Price Chart Spero Therapeutics Stock Price Chart DiaMedica Therapeutics Stock Price Chart Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ATNM) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATNM Stock Alerts